Request for Covid-19 Impact Assessment of this Report
In addition to providing operational advantages to healthcare organisations in terms of revenue management cycleand integration of the health records, it is an effective tool for stratifying population to fulfil public health priorities on epidemiological basis. It can be of great value in national preventive care, empowering patients with rights, health policy recommendation, public health financing, intelligent government expenditure in health infrastructure, and in facilitatingimplementation of healthcare laws for patient safety in developing nations.
Market Dynamics
The major factors driving the growth of Healthcare Analytics market are as under:
1. Increased demand to curb the rising healthcare expenses, better healthcare facilities, improved patient outcomes.
2. Increasing number of patient data coupled with increased usage of data sharing social platforms and blogs will drive the market towards healthcare analytics.
3. Rising awareness about technologies in the field of personalised medicines and improving healthcare infrastructure coupled with incentives and policies in favour of value based and cloud based analytics are also
major drivers of this market.
The major factors which hinder the growth of Healthcare analytics market are as under:
1. The dearth of skilled professionals and IT technicians with sufficient knowledge base and technical expertise.
2. High initial investments and high cost of the analytics solutions coupled with uncertain returns on investment.
3. Data security, breach of confidentiality pertaining to patient's data, dearth of structures for integrating and sharing data.
4. Trouble in establishing a global healthcare network due to fragmented international political and economic relations.
Market Segmentation
The Healthcare Analytics market is bifurcated on the basis of type, delivery mode, application, end user and region. Detailed segmentation is presented as below:
--> On the basis of Type
o Predictive Analysis
o Descriptive Analysis
o Prescriptive Analysis
Out of these descriptive analysis shares and is expected to share the largest share in this segment owing to its use by medical providers to understand the pattern of past records.
--> On the basis of Delivery Model
o On-Demand Model
o On-Premise Model
In this segment the On-Demand model is expected to show the highest growth owing to its pay-as-you-go model, no capital for hardware instalment.
--> On the basis of Application
o Operational and Administrative Analytics
-> Workforce Management
-> Supply Chain Management
-> Strategic Analysis
o Financial Analytics'
-> Claims Processing
-> Fraud, Waste and Abuse (FWA)
-> Risk Adjustment
-> Payment Integrity
-> Revenue Cycle Management (RCM)
o Population Health Analytics
o Clinical Analytics
-> Quality Improvement & Clinical Benchmarking
-> Comparative Analytics/Comparative Effectiveness
-> Clinical Decision Support
-> Precision Health
-> Reporting and Compliance
--> On the basis of End User
o Providers
-> Post-acute Organizations
-> Hospitals, Physician Practices, and IDNs
-> Ambulatory Settings
o Payers
-> Government Agencies
-> Private Insurance Companies
-> Employers & Private Exchanges
--> On the basis of Component
o Services
o Software
o Hardware
--> On the basis of Region
o North America
o Europe
o Asia Pacific
Geographic Analysis
Geographically the market is segmented into following different regions:North America, Europe, Asia Pacific and rest of the world (RoW). North America shares the largest share in the global market and is even expected to be the region showing the highest CAGR in the forecast period. This significant share is attributed to four main factors:
1. The presence of a large of key players base in the region.
2. Openness of the region to adopt advanced technologies coupled with increasing adoption of Electronic Health Records (EHR) across all hospital platforms.
3. Improvement and advancement in healthcare infrastructure further propelled by capital fundings by various players.
4. Government role to reduce increasing medical costs and provide quality healthcare in the form of incentives, legislations like the EHR and other regulations to provide personalised medicines to people.
After this Europe is the next big share holder followed by Asia Pacific. In Asia Pacific, Japan has the largest market share and this is attributed to increasing initiatives b government to reduce the rising costs on medical treatment coupled with increase expenditure on medical needs and use of predictive and prescriptive methods across various hospital platforms.
Key Players
The key players who are driving the market of Healthcare Analytics and determine its future are: IBM Corporation (U.S.A.), Allscripts Health Solutions (U.S.A.), Inovalon (U.S.A.), Oracle Corporation (U.S.A.),Cognizant, Health Catalyst, Med Assets, Inc., McKesson Corporation, SAS Institute Inc.(USA), Truven Health Analytics,Verisk Health(USA), Optum Health(USA), McKesson Corporation(USA), Cerner Corporation(USA), Athena health,Computer Programs and Systems, Change Healthcare, Tenet Healthcare Corporation, GE Healthcare, Evolent Health, Influence Health and Health Catalyst(USA), Mede Analytics, Inc. (U.S.A).
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
1.1. Market Definition
1.2. Market Taxonomy
2. Research Methodology
3. Assumptions and Acronyms
4. Executive Summary
5. Consumer Analysis
5.1. Consumer Profile (Demographic, Geographic, etc.)
5.2. Consumer Motivation
5.3. Procurement Process
5.4. Frequency of Buying
6. Historical Overview (Market Origins, Product Launch Timeline, etc.)
7. Pricing Analysis
8. Market Dynamics
8.1. Macroeconomic Factors
8.2. Drivers
8.2.1. Supply Side
8.2.2. Demand Side
8.3. Restraints
8.4. Opportunities
9. R&D Status and Technology Overview
10. Global Healthcare Analytics Market Analysis, By Data Source
10.1. Introduction
10.2. Prominent Trends
10.3. Regulatory Guidelines
10.4. Market Size and Analysis, By Data Source
10.4.1. Internal Data
10.4.1.1. Patient Data
10.4.1.2. Hospital Data
10.4.1.3. Diagnosis & Treatment Data
10.4.1.4. Medical Imaging Data
10.4.2. External Data
10.4.2.1. Benchmarks Data
10.4.2.2. Public Health Database
10.4.2.3. Government Data
10.4.3. Insurance Data
10.4.4. Pharmacy Data
10.4.5. Social Media Data
10.4.6. Mobile Data
10.5. Market Share Analysis and YoY Growth Rates, By Data Source
11. Global Healthcare Analytics Market Analysis, By Deployment
11.1. Introduction
11.2. Prominent Trends
11.3. Regulatory Guidelines
11.4. Market Size and Analysis, By Deployment
11.4.1. On-Premises
11.4.2. Cloud Based Systems
11.5. Market Share Analysis and YoY Growth Rates, By Deployment
12. Global Healthcare Analytics Market Analysis, By Tools
12.1. Introduction
12.2. Prominent Trends
12.3. Regulatory Guidelines
12.4. Market Size and Analysis, By Tools
12.4.1. Reporting & Dash-boarding Tools
12.4.2. Querying, OLAP and Data Mining Tools
12.4.3. Predictive Modelling Tools
12.4.4. Clinical Health Repositories & Governance
12.4.5. Combination Products
12.5. Market Share Analysis and YoY Growth Rates, By Tools
13. Global Healthcare Analytics Market Analysis, By Consumer
13.1. Introduction
13.2. Prominent Trends
13.3. Regulatory Guidelines
13.4. Market Size and Analysis, By Consumer
13.4.1. Hospitals
13.4.2. Insurance Companies
13.4.3. HMOs
13.4.4. Government Agencies
13.4.5. Pharmacy
13.4.6. Biotechnology
13.4.7. Others
13.5. Market Share Analysis and YoY Growth Rates, By Consumer
14. Global Healthcare Analytics Market Analysis, By Services
14.1. Introduction
14.2. Prominent Trends
14.3. Regulatory Guidelines
14.4. Market Size and Analysis, By Services
14.4.1. Patient Safety Management
14.4.1.1. Clinical Decision Support
14.4.1.2. Anaesthetics Administration
14.4.1.3. Resource Management
14.4.1.4. Emergency Services
14.4.1.5. Others
14.4.2. Clinical Outcomes Management
14.4.2.1. Accountable Care Organisations
14.4.2.2. Others
14.4.3. Wellness & Disease Management
14.4.3.1. Chronic Disease Management
14.4.3.2. Preventive Medicine
14.4.3.3. Population Health Management
14.4.3.4. Others
14.4.4. Hospital Performance Management
14.4.4.1. Feedback Analysis
14.4.4.2. Social Media Analytics
14.4.5. Discovery Analytics [New Gen]
14.4.6. Others
14.5. Market Share Analysis and YoY Growth Rates, By Services
15. Global Healthcare Analytics Market Analysis, By Region
15.1. Introduction
15.2. Prominent Trends
15.3. Regulatory Guidelines
15.4. Market Size and Analysis, By Region
15.4.1. North America
15.4.2. Latin America
15.4.3. Europe
15.4.4. Asia Pacific
15.4.5. Middle East & Africa (MEA)
15.5. Market Share Analysis and YoY Growth Rates, By Region
16. North America Healthcare Analytics Market Analysis
16.1. Introduction
16.2. Prominent Trends
16.3. North America Healthcare Analytics Market Analysis, By Country
16.3.1. U.S.
16.3.2. Canada
16.4. North America Healthcare Analytics Market Size and Analysis, By Data Source
16.4.1. Internal Data
16.4.1.1. Patient Data
16.4.1.2. Hospital Data
16.4.1.3. Diagnosis & Treatment Data
16.4.1.4. Medical Imaging Data
16.4.2. External Data
16.4.2.1. Benchmarks Data
16.4.2.2. Public Health Database
16.4.2.3. Government Data
16.4.3. Insurance Data
16.4.4. Pharmacy Data
16.4.5. Social Media Data
16.4.6. Mobile Data
16.5. North America Healthcare Analytics Market Size and Analysis, By Deployment
16.5.1. On-Premises
16.5.2. Cloud Based Systems
16.6. North America Healthcare Analytics Market Size and Analysis, By Tools
16.6.1. Reporting & Dash-boarding Tools
16.6.2. Querying, OLAP and Data Mining Tools
16.6.3. Predictive Modelling Tools
16.6.4. Clinical Health Repositories & Governance
16.6.5. Combination Products
16.7. North America Healthcare Analytics Market Size and Analysis, By Consumer
16.7.1. Hospitals
16.7.2. Insurance Companies
16.7.3. HMOs
16.7.4. Government Agencies
16.7.5. Pharmacy
16.7.6. Biotechnology
16.7.7. Others
16.8. North America Healthcare Analytics Market Size and Analysis, By Services
16.8.1. Patient Safety Management
16.8.1.1. Clinical Decision Support
16.8.1.2. Anaesthetics Administration
16.8.1.3. Resource Management
16.8.1.4. Emergency Services
16.8.1.5. Others
16.8.2. Clinical Outcomes Management
16.8.2.1. Accountable Care Organisations
16.8.2.2. Others
16.8.3. Wellness & Disease Management
16.8.3.1. Chronic Disease Management
16.8.3.2. Preventive Medicine
16.8.3.3. Population Health Management
16.8.3.4. Others
16.8.4. Hospital Performance Management
16.8.4.1. Feedback Analysis
16.8.4.2. Social Media Analytics
16.8.5. Discovery Analytics [New Gen]
16.8.6. Others
16.9. North America Healthcare Analytics Market Share Analysis and YoY Growth Rates
16.9.1. By Data Source
16.9.2. By Deployment
16.9.3. By Tools
16.9.4. By Consumer
16.9.5. By Services
17. Latin America Healthcare Analytics Market Analysis
17.1. Introduction
17.2. Prominent Trends
17.3. Latin America Healthcare Analytics Market Analysis, By Country
17.3.1. Mexico
17.3.2. Brazil
17.3.3. Others
17.4. Latin America Healthcare Analytics Market Size and Analysis, By Data Source
17.4.1. Internal Data
17.4.1.1. Patient Data
17.4.1.2. Hospital Data
17.4.1.3. Diagnosis & Treatment Data
17.4.1.4. Medical Imaging Data
17.4.2. External Data
17.4.2.1. Benchmarks Data
17.4.2.2. Public Health Database
17.4.2.3. Government Data
17.4.3. Insurance Data
17.4.4. Pharmacy Data
17.4.5. Social Media Data
17.4.6. Mobile Data
17.5. Latin America Healthcare Analytics Market Size and Analysis, By Deployment
17.5.1. On-Premises
17.5.2. Cloud Based Systems
17.6. Latin America Healthcare Analytics Market Size and Analysis, By Tools
17.6.1. Reporting & Dash-boarding Tools
17.6.2. Querying, OLAP and Data Mining Tools
17.6.3. Predictive Modelling Tools
17.6.4. Clinical Health Repositories & Governance
17.6.5. Combination Products
17.7. Latin America Healthcare Analytics Market Size and Analysis, By Consumer
17.7.1. Hospitals
17.7.2. Insurance Companies
17.7.3. HMOs
17.7.4. Government Agencies
17.7.5. Pharmacy
17.7.6. Biotechnology
17.7.7. Others
17.8. Latin America Healthcare Analytics Market Size and Analysis, By Services
17.8.1. Patient Safety Management
17.8.1.1. Clinical Decision Support
17.8.1.2. Anaesthetics Administration
17.8.1.3. Resource Management
17.8.1.4. Emergency Services
17.8.1.5. Others
17.8.2. Clinical Outcomes Management
17.8.2.1. Accountable Care Organisations
17.8.2.2. Others
17.8.3. Wellness & Disease Management
17.8.3.1. Chronic Disease Management
17.8.3.2. Preventive Medicine
17.8.3.3. Population Health Management
17.8.3.4. Others
17.8.4. Hospital Performance Management
17.8.4.1. Feedback Analysis
17.8.4.2. Social Media Analytics
17.8.5. Discovery Analytics [New Gen]
17.8.6. Others
17.9. Latin America Healthcare Analytics Market Share Analysis and YoY Growth Rates
17.9.1. By Data Source
17.9.2. By Deployment
17.9.3. By Tools
17.9.4. By Consumer
17.9.5. By Services
18. Europe Healthcare Analytics Market Analysis
18.1. Introduction
18.2. Prominent Trends
18.3. Europe Healthcare Analytics Market Analysis, By Country
18.3.1. Germany
18.3.2. U.K.
18.3.3. Spain
18.3.4. France
18.3.5. Italy
18.3.6. Russia
18.3.7. Others
18.4. Europe Healthcare Analytics Market Size and Analysis, By Data Source
18.4.1. Internal Data
18.4.1.1. Patient Data
18.4.1.2. Hospital Data
18.4.1.3. Diagnosis & Treatment Data
18.4.1.4. Medical Imaging Data
18.4.2. External Data
18.4.2.1. Benchmarks Data
18.4.2.2. Public Health Database
18.4.2.3. Government Data
18.4.3. Insurance Data
18.4.4. Pharmacy Data
18.4.5. Social Media Data
18.4.6. Mobile Data
18.5. Europe Healthcare Analytics Market Size and Analysis, By Deployment
18.5.1. On-Premises
18.5.2. Cloud Based Systems
18.6. Europe Healthcare Analytics Market Size and Analysis, By Tools
18.6.1. Reporting & Dash-boarding Tools
18.6.2. Querying, OLAP and Data Mining Tools
18.6.3. Predictive Modelling Tools
18.6.4. Clinical Health Repositories & Governance
18.6.5. Combination Products
18.7. Europe Healthcare Analytics Market Size and Analysis, By Consumer
18.7.1. Hospitals
18.7.2. Insurance Companies
18.7.3. HMOs
18.7.4. Government Agencies
18.7.5. Pharmacy
18.7.6. Biotechnology
18.7.7. Others
18.8. Europe Healthcare Analytics Market Size and Analysis, By Services
18.8.1. Patient Safety Management
18.8.1.1. Clinical Decision Support
18.8.1.2. Anaesthetics Administration
18.8.1.3. Resource Management
18.8.1.4. Emergency Services
18.8.1.5. Others
18.8.2. Clinical Outcomes Management
18.8.2.1. Accountable Care Organisations
18.8.2.2. Others
18.8.3. Wellness & Disease Management
18.8.3.1. Chronic Disease Management
18.8.3.2. Preventive Medicine
18.8.3.3. Population Health Management
18.8.3.4. Others
18.8.4. Hospital Performance Management
18.8.4.1. Feedback Analysis
18.8.4.2. Social Media Analytics
18.8.5. Discovery Analytics [New Gen]
18.8.6. Others
18.9. Europe Healthcare Analytics Market Share Analysis and YoY Growth Rates
18.9.1. By Data Source
18.9.2. By Deployment
18.9.3. By Tools
18.9.4. By Consumer
18.9.5. By Services
19. Asia Pacific Healthcare Analytics Market Analysis
19.1. Introduction
19.2. Prominent Trends
19.3. Asia Pacific Healthcare Analytics Market Analysis, By Country
19.3.1. India
19.3.2. China
19.3.3. Australia & New Zealand
19.3.4. Japan
19.3.5. Others
19.4. Asia Pacific Healthcare Analytics Market Size and Analysis, By Data Source
19.4.1. Internal Data
19.4.1.1. Patient Data
19.4.1.2. Hospital Data
19.4.1.3. Diagnosis & Treatment Data
19.4.1.4. Medical Imaging Data
19.4.2. External Data
19.4.2.1. Benchmarks Data
19.4.2.2. Public Health Database
19.4.2.3. Government Data
19.4.3. Insurance Data
19.4.4. Pharmacy Data
19.4.5. Social Media Data
19.4.6. Mobile Data
19.5. Asia Pacific Healthcare Analytics Market Size and Analysis, By Deployment
19.5.1. On-Premises
19.5.2. Cloud Based Systems
19.6. Asia Pacific Healthcare Analytics Market Size and Analysis, By Tools
19.6.1. Reporting & Dash-boarding Tools
19.6.2. Querying, OLAP and Data Mining Tools
19.6.3. Predictive Modelling Tools
19.6.4. Clinical Health Repositories & Governance
19.6.5. Combination Products
19.7. Asia Pacific Healthcare Analytics Market Size and Analysis, By Consumer
19.7.1. Hospitals
19.7.2. Insurance Companies
19.7.3. HMOs
19.7.4. Government Agencies
19.7.5. Pharmacy
19.7.6. Biotechnology
19.7.7. Others
19.8. Asia Pacific Healthcare Analytics Market Size and Analysis, By Services
19.8.1. Patient Safety Management
19.8.1.1. Clinical Decision Support
19.8.1.2. Anaesthetics Administration
19.8.1.3. Resource Management
19.8.1.4. Emergency Services
19.8.1.5. Others
19.8.2. Clinical Outcomes Management
19.8.2.1. Accountable Care Organisations
19.8.2.2. Others
19.8.3. Wellness & Disease Management
19.8.3.1. Chronic Disease Management
19.8.3.2. Preventive Medicine
19.8.3.3. Population Health Management
19.8.3.4. Others
19.8.4. Hospital Performance Management
19.8.4.1. Feedback Analysis
19.8.4.2. Social Media Analytics
19.8.5. Discovery Analytics [New Gen]
19.8.6. Others
19.9. Asia Pacific Healthcare Analytics Market Share Analysis and YoY Growth Rates
19.9.1. By Data Source
19.9.2. By Deployment
19.9.3. By Tools
19.9.4. By Consumer
19.9.5. By Services
20. Middle East and Africa (MEA) Healthcare Analytics Market Analysis
20.1. Introduction
20.2. Prominent Trends
20.3. Middle East and Africa (MEA) Healthcare Analytics Market Analysis, By Country
20.3.1. GCC Countries
20.3.2. South Africa
20.3.3. North Africa
20.3.4. Rest of Middle East and Africa
20.4. Middle East and Africa (MEA) Healthcare Analytics Market Size and Analysis, By Data Source
20.4.1. Internal Data
20.4.1.1. Patient Data
20.4.1.2. Hospital Data
20.4.1.3. Diagnosis & Treatment Data
20.4.1.4. Medical Imaging Data
20.4.2. External Data
20.4.2.1. Benchmarks Data
20.4.2.2. Public Health Database
20.4.2.3. Government Data
20.4.3. Insurance Data
20.4.4. Pharmacy Data
20.4.5. Social Media Data
20.4.6. Mobile Data
20.5. Middle East and Africa (MEA) Healthcare Analytics Market Size and Analysis, By Deployment
20.5.1. On-Premises
20.5.2. Cloud Based Systems
20.6. Middle East and Africa (MEA) Healthcare Analytics Market Size and Analysis, By Tools
20.6.1. Reporting & Dash-boarding Tools
20.6.2. Querying, OLAP and Data Mining Tools
20.6.3. Predictive Modelling Tools
20.6.4. Clinical Health Repositories & Governance
20.6.5. Combination Products
20.7. Middle East and Africa (MEA) Healthcare Analytics Market Size and Analysis, By Consumer
20.7.1. Hospitals
20.7.2. Insurance Companies
20.7.3. HMOs
20.7.4. Government Agencies
20.7.5. Pharmacy
20.7.6. Biotechnology
20.7.7. Others
20.8. Middle East and Africa (MEA) Healthcare Analytics Market Size and Analysis, By Services
20.8.1. Patient Safety Management
20.8.1.1. Clinical Decision Support
20.8.1.2. Anaesthetics Administration
20.8.1.3. Resource Management
20.8.1.4. Emergency Services
20.8.1.5. Others
20.8.2. Clinical Outcomes Management
20.8.2.1. Accountable Care Organisations
20.8.2.2. Others
20.8.3. Wellness & Disease Management
20.8.3.1. Chronic Disease Management
20.8.3.2. Preventive Medicine
20.8.3.3. Population Health Management
20.8.3.4. Others
20.8.4. Hospital Performance Management
20.8.4.1. Feedback Analysis
20.8.4.2. Social Media Analytics
20.8.5. Discovery Analytics [New Gen]
20.8.6. Others
20.9. Middle East and Africa (MEA) Healthcare Analytics Market Share Analysis and YoY Growth Rates
20.9.1. By Data Source
20.9.2. By Deployment
20.9.3. By Tools
20.9.4. By Consumer
20.9.5. By Services
21. Industry Structure
21.1. Porters Five Forces Analysis
21.1.1. Bargaining Power of Suppliers
21.1.2. Bargaining Power of Buyers
21.1.3. Threat of New Entrants
21.1.4. Threat of Substitute Products and Services
21.1.5. Internal Rivalry
21.2. Supply Chain Analysis and Profitability Margins
21.3. Market Share Analysis
21.4. Strategic Analysis
21.4.1. Competitive Strategies
21.4.2. Mergers & Acquisitions Activity
21.4.3. Co-operative Agreements
21.5. Critical Success Factor (CSF) Analysis (Technology & Manufacturing, Design & Features, Brand Reputation, Distribution Network, Marketing)
21.6. Company Profiles (Overview, Product/Service Details, Geographic Scope, Financials, Strategic Intent & Approach, Core Competencies & Competitive Advantage and Key developments)
21.6.1. IBM
21.6.2. Wipro
21.6.3. Allscripts
21.6.4. Tableau
21.6.5. Cerner Corporation
21.6.6. Health Catalyst
21.6.7. Inovalon
21.6.8. McKesson
21.6.9. MEDEANALYTICS
21.6.10. Optum
21.6.11. Oracle
21.6.12. SAS Institute
21.6.13. SCIOInspire
21.6.14. Verscend Technologies
21.6.15. CitiusTech
21.6.16. Vitreos Health
21.6.17. Ikon Tech IQVIA
21.6.18. GENERAL ELECTRIC
22. Prognosis for the Future
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...